William Hayes - REDFILED (Page 3)

ARBK

ARGO BLOCKCHAIN CEO Justin Nolan Departs With $250,000 Payout

Argo Blockchain says Justin Nolan ceased to be CEO effective August 30, 2026, and has begun a search for a permanent successor with AI infrastructure experience.

Gulf Resources produces bromine, crude salt and chemical products in Shandong province.

GURE

GULF RESOURCES Files 8-K on Nasdaq Listing Deficiency

The Shandong-based chemicals producer disclosed an Item 3.01 notice covering delisting or failure to satisfy a continued listing rule.

TAK

TAKEDA Terminates Phase 3 Soticlestat Study in Dravet and Lennox-Gastaut

Takeda has halted a Phase 3 trial of soticlestat in epilepsy patients previously exposed to fenfluramine, citing a business decision unrelated to patient safety.

Quince Therapeutics disclosed a continued listing matter in a filing with the SEC.

QNCX

QUINCE THERAPEUTICS Files 8-K Flagging Listing Rule Issue

The biotech filed an Item 3.01 disclosure with the SEC covering a delisting notice or failure to meet a continued listing standard, dated August 31, 2026.

Pro-Dex manufactures battery-powered surgical drivers and shavers used in orthopedic procedures.

PDEX

PRO-DEX Posts 17% Q4 Sales Growth as Gross Margin Jumps to 35%

The surgical device maker reported fiscal 2026 net sales of $77.5 million and full-year diluted EPS of $4.12, helped by its largest customer's next-generation handpiece.

TMUS

T-MOBILE Names Ex-Shell CFO Jessica Uhl as Osvaldik Heads for Retirement

Jessica Uhl joins T-Mobile as CFO Designate in mid-September and takes over from Peter Osvaldik in February 2027; 2026 guidance reaffirmed.

Latigo is developing non-opioid NaV1.8 inhibitors for acute and chronic pain.

LTGO

LATIGO Posts First Results Since $397M IPO, Phase 3 Set for Late 2026

Latigo Biotherapeutics reported a $25.8 million second-quarter loss and said IPO proceeds fund operations into 2029 as onzotrigine heads to Phase 3.

NX

QUANEX Posts $0.79 Adjusted EPS as Margins Widen, Repays $42M Debt

Quanex reported fiscal third-quarter net sales of $501.8 million, up 1.3%, swinging to a $26.5 million profit after last year's goodwill writedown.

NVO

NOVO NORDISK Completes Phase 3 Trial of CagriSema Against Tirzepatide

The Danish drugmaker's head-to-head Phase 3 study of CagriSema versus Eli Lilly's tirzepatide in type 2 diabetes is now listed as completed.

Senti Biosciences develops gene circuit-based cell therapies.

SNTI

SENTI BIOSCIENCES Files Amended Terms for Senior Secured Convertible Notes

An 8-K discloses a revised form of senior secured convertible note maturing November 23, 2026, repayable in cash at 200% of outstanding principal.

Luca Ferrari, co-founder and chief executive officer of Bending Spoons.

BSP

BENDING SPOONS Completes Acquisition of Airtable

The Milan-based app owner closed its previously announced purchase of all outstanding shares of Formagrid, the company behind Airtable, on September 4.

BrasilAgro farms row crops, sugarcane and cattle across Brazil and Paraguay.

LND

BRASILAGRO Guides to 452,900 Tons for 2026/27 as El Niño Reshapes Crop Mix

The Brazilian farmland operator plans 165,208 hectares next season, cutting first-crop cotton 70% and dropping second-crop beans while lifting corn and pasture.